![Camilla Myhre Sandberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Camilla Myhre Sandberg
Directeur Général chez
MIRIS HOLDING AB
Profil
Camilla Myhre Sandberg is currently the Chief Executive Officer at Miris Holding AB since 2016.
Ms. Sandberg is also an Independent Director at Monivent AB and at NextCell Pharma AB since 2017.
Formerly, Ms. Sandberg was Vice President-Sales & Marketing at BioLamina AB. Ms. Sandberg completed undergraduate studies in 1996 and earned an MBA in 1998 from the University of Oslo.
Postes actifs de Camilla Myhre Sandberg
| Sociétés | Poste | Début |
|---|---|---|
| MIRIS HOLDING AB | Directeur Général | 04/10/2016 |
| NEXTCELL PHARMA AB | Directeur/Membre du Conseil | 01/01/2017 |
| MONIVENT AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Camilla Myhre Sandberg
| Sociétés | Poste | Fin |
|---|---|---|
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Sales & Marketing | - |
Formation de Camilla Myhre Sandberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Miris Holding AB
 Miris Holding AB Electronic Equipment/InstrumentsElectronic Technology Produces and markets analytical instruments for analyzing fluids | Electronic Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells | Health Technology |
Monivent AB
 Monivent AB Medical SpecialtiesHealth Technology Develops device to monitor manual ventilation given to newborns unable to breathe | Health Technology |
NextCell Pharma AB
 NextCell Pharma AB Pharmaceuticals: MajorHealth Technology Develops investigational medicinal products | Health Technology |
